Shopping Cart 0
Cart Subtotal
USD 0

University of Mississippi - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

University of Mississippi (UOM) is an educational service provider that offers graduation training and research programs. The university offers undergraduate and graduate courses and research programs. It offers training programs in the fields of applied science, business administration, engineering, journalism, law, liberal arts, nursing, and pharmacy, among others. UOM also provides educational courses in dentistry, health related professions, nursing, medicine and health sciences. The university offers research programs in acoustics, atmospheric physics, health care, remote sensing, Southern studies, space law and pharmaceutical sciences. It also offers campus programs, computer help and labs, emergency service, library and other recreational facilities. UOM is headquartered in Oxford, Mississippi, the US.

University of Mississippi-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

University of Mississippi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Mississippi, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Mississippi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Mississippi, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Mississippi, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

University of Mississippi, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Nemus Bioscience Enters into Research Agreement with University of Mississippi for CIPN 10

University of Mississippi and Nemus Enter into Research Agreement For Glaucoma Treatment 11

University of Mississippi and Nemus Enter into Research Agreement For CBD Formulations 12

Nemus Bioscience Enters into Research Agreement with University of Mississippi 13

Nemus Enters into Research Agreement with University of Mississippi for MRSA 14

Nemus Bioscience Enters into Research Agreement with University of Mississippi 15

Licensing Agreements 16

Nemus Bioscience Enters into Licensing Agreement University of Mississippi 16

Nemus Bioscience Enters into Licensing Agreement with University of Mississippi for UM 8930 17

Nemus Bioscience Renews its Option Agreement with University of Mississippi 18

Nemus Enters into Licensing Agreement with University of Mississippi for UM 1490, UM 5070 and UM 8790 19

Hapten Sciences Enters into Licensing Agreement with ElSohly Labs and University of Mississippi 20

ChromaDex Enters into Licensing Agreement with University of Mississippi 21

University of Mississippi-Key Competitors 22

University of Mississippi-Key Employees 23

University of Mississippi-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Government and Public Interest 25

Nov 09, 2017: W.K. Kellogg Foundation Grants The Rogosin Institute USD1.858 Million for Programs to Improve Health Outcomes and Economic Equity in the Mississippi Delta 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 26


List Of Figure

List of Figures

University of Mississippi, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Mississippi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Mississippi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Mississippi, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Mississippi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Mississippi, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

University of Mississippi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Mississippi, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

University of Mississippi, Pharmaceuticals & Healthcare, Key Facts 2

University of Mississippi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Mississippi, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Mississippi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Mississippi, Deals By Therapy Area, 2012 to YTD 2018 8

University of Mississippi, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Nemus Bioscience Enters into Research Agreement with University of Mississippi for CIPN 10

University of Mississippi and Nemus Enter into Research Agreement For Glaucoma Treatment 11

University of Mississippi and Nemus Enter into Research Agreement For CBD Formulations 12

Nemus Bioscience Enters into Research Agreement with University of Mississippi 13

Nemus Enters into Research Agreement with University of Mississippi for MRSA 14

Nemus Bioscience Enters into Research Agreement with University of Mississippi 15

Nemus Bioscience Enters into Licensing Agreement University of Mississippi 16

Nemus Bioscience Enters into Licensing Agreement with University of Mississippi for UM 8930 17

Nemus Bioscience Renews its Option Agreement with University of Mississippi 18

Nemus Enters into Licensing Agreement with University of Mississippi for UM 1490, UM 5070 and UM 8790 19

Hapten Sciences Enters into Licensing Agreement with ElSohly Labs and University of Mississippi 20

ChromaDex Enters into Licensing Agreement with University of Mississippi 21

University of Mississippi, Key Competitors 22

University of Mississippi, Key Employees 23

University of Mississippi, Subsidiaries 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

University of Mississippi, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.